Skip to main content
VRCA logo

VRCA · Verrica Pharmaceuticals Inc. · Documents

Track VRCA — free
$3.56 -0.16 (-4.30%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Market Cap
$61.16M
Shares
17.18M
Volume · Nov 13 18.68K Avg daily vol (3M) 72.22K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Feb 29
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $5.12M ▼ 43.3% Net loss $67M Diluted EPS -$1.48
2023
Mar 6
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $9.03M ▼ 24.7% Net loss $24.49M Diluted EPS -$0.72
2022
Showing 51–100 of 153 documents
Key facts CIK 1660334 CUSIP 92511W207 13F (30d) 46 filings 25 filers Visit website Investor relations